Pebblebrook Hotel Trust (PEB) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.11	$0.17	+54.5%	—	$407.1M	—
Q1 26	-$0.34	-$0.23	+32.4%	—	$345.7M	—
Q4 25	-$0.31	-$0.23	+25.8%	—	$349M	—
Q3 25	-$0.01	-$0.37	-3600.0%	—	$398.7M	—
Q2 25	$0.06	$0.06	0.0%	—	$407.5M	—
Q1 25	-$0.38	-$0.37	+2.6%	—	$320.3M	—
Q4 24	-$0.41	-$0.33	+19.5%	—	$337.6M	—
Q3 24	-$0.02	$0.24	+1300.0%	—	$404.5M	—
Q2 24	$0.08	$0.15	+87.5%	—	$397.1M	—
Q1 24	-$0.44	-$0.32	+27.3%	—	$314.1M	—
Q4 23	-$0.32	-$0.26	+18.8%	—	$334.1M	—
Q3 23	$0.06	-$0.57	-1050.0%	—	$395.8M	—
Q2 23	$0.2	$0.24	+20.0%	—	$384.3M	—
Q1 23	-$0.42	-$0.27	+35.7%	—	$305.7M	—
Q4 22	-$0.25	-$0.34	-36.0%	—	$319.6M	—
Q3 22	$0.16	$0.1	-37.5%	—	$416.7M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$0.9	—	—	$1.5B	—
FY24	—	-$0.39	—	—	$1.5B	—
FY23	—	-$0.93	—	—	$1.4B	—
FY22	—	-$0.95	—	—	$1.4B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$816.4M	$769.3M	$828.7M	$1.6B	$442.9M	$733M	$1.4B	$1.4B	$1.5B	$1.5B
YoY change	+5.91%	-5.77%	+7.72%	+94.6%	-72.5%	+65.5%	+89.9%	+2.02%	+2.35%	+1.53%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	816.4M	769.3M	828.7M	1.6B	442.9M	733M	1.4B	1.4B	1.5B	1.5B
Cost of revenue	534.4M	516.5M	566M	1.1B	493.8M	608.3M	1B	1.1B	1.1B	1.1B
Gross profit	282M	252.8M	262.7M	513M	-50.9M	124.8M	382.3M	354.3M	366.1M	356.6M
Gross margin	34.5%	32.9%	31.7%	31.8%	-11.5%	17%	27.5%	24.9%	25.2%	24.2%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	27.9M	20.1M	20.9M	34M	45.2M	38.2M	39.2M	44.8M	48.1M	49.5M
Operating expenses	27.9M	30M	10M	43M	49.6M	40.2M	44.5M	57.4M	53M	53.7M
Operating income	151.7M	120.6M	144.2M	235.2M	-325M	-139.7M	98.2M	56.2M	83.6M	75.2M
Operating margin	18.6%	15.7%	17.4%	14.6%	-73.4%	-19.1%	7.05%	3.96%	5.75%	5.1%
Non-operating income, net	-36.2M	17.2M	-75.1M	-5.8M	32.8M	50M	-82.9M	-14.2M	3.2M	-27.9M
Pretax income	73.8M	100.4M	15.1M	120.9M	-396.3M	-186.3M	-84.7M	-73.6M	-25.6M	-55.9M
Income tax	-134K	181K	1.7M	5.2M	-3.7M	61K	277K	655K	-25.6M	6.3M
Net income	74M	100.3M	13.4M	115.7M	-392.6M	-186.4M	-85M	-74.3M	16K	-62.2M
Net margin	9.06%	13%	1.62%	7.18%	-88.6%	-25.4%	-6.11%	-5.23%	0%	-4.22%
EBITDA	188.8M	222.8M	252.2M	463M	-107.2M	75M	321.8M	293M	306M	304.5M
EPS	0.65	1.2	-0.06	0.63	-3.25	-1.8	-0.95	-0.93	-0.39	-0.9
Diluted EPS	0.64	1.19	-0.06	0.63	-3.25	-1.8	-0.95	-0.93	-0.39	-0.9

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	395.8M	334.1M	314.1M	397.1M	404.5M	337.6M	320.3M	407.5M	398.7M	349M	345.7M	407.1M
Cost of revenue	282.7M	264.2M	248.5M	272.7M	292.3M	273.8M	260.5M	287.8M	294.5M	276.2M	264.9M	284.8M
Gross profit	113.1M	69.9M	65.6M	124.5M	112.2M	63.8M	59.8M	119.8M	104.3M	72.8M	80.8M	122.4M
Gross margin	28.6%	20.9%	20.9%	31.3%	27.7%	18.9%	18.7%	29.4%	26.2%	20.8%	23.4%	30.1%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	11.5M	12.1M	12.2M	11.9M	11.8M	12.1M	13.2M	12.5M	12.1M	11.7M	12M	11.9M
Operating expenses	15.4M	14.8M	13.8M	13.5M	12.8M	13M	13.8M	13M	14.3M	12.7M	13.1M	11.9M
Operating income	34.5M	-5.9M	-5.4M	53.7M	41.9M	-6.6M	-11.5M	49.1M	32.4M	5.2M	15.7M	58.4M
Operating margin	8.71%	-1.78%	-1.71%	13.5%	10.4%	-1.96%	-3.6%	12.1%	8.13%	1.5%	4.55%	14.3%
Non-operating income, net	-59.1M	-8.5M	4.3M	7.5M	5.9M	-14.5M	3.3M	5.2M	-41.6M	5.2M	-7.9M	332K
Pretax income	-55.7M	-42.1M	-27.5M	33.2M	19.9M	-51.3M	-35.3M	27.1M	-29.4M	-18.3M	-18.5M	32.6M
Income tax	822K	-198K	46K	1M	-25.2M	-1.5M	-3.2M	7.8M	3M	-1.4M	-17K	7.7M
Net income	-56.5M	-41.9M	-27.5M	32.2M	45.1M	-49.8M	-32.2M	19.3M	-32.4M	-17M	-18.4M	24.9M
Net margin	-14.3%	-12.6%	-8.76%	8.12%	11.2%	-14.8%	-10%	4.73%	-8.11%	-4.87%	-5.33%	6.12%
EBITDA	96.4M	55.2M	51.7M	109.6M	98.7M	47.2M	43.1M	106.9M	96.3M	58.3M	64.4M	109.3M
EPS	-0.57	—	-0.32	0.17	0.27	-0.51	-0.37	0.06	-0.37	-0.23	-0.26	0.18
Diluted EPS	-0.57	—	-0.32	0.16	0.24	-0.51	-0.37	0.06	-0.37	-0.23	-0.26	0.17

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	2.1B	2.6B	2.1B	—	2.5B	2.9B	1.7B	1.9B	1.6B	1.3B	2.1B
Enterprise value	3.2B	3.5B	4.8B	—	5.1B	5.6B	4.4B	4.4B	4B	3.6B	4.4B
Shares outstanding	71.9M	69.6M	74.3M	130.5M	130.6M	130.8M	130.5M	121.8M	119.8M	117M	117M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	28.9	25.8	157.1	—	—	—	—	—	101.4K	—	-20.8
P/S	2.62	3.36	2.54	—	5.54	3.99	1.25	1.37	1.12	0.9	1.4
P/B	1.33	1.72	0.56	—	0.75	0.92	0.57	0.68	0.58	0.52	0.87
EV/EBITDA	16.9	15.7	18.9	—	-47.8	75.1	13.7	15	13	11.8	13.3
EV/Sales	3.9	4.54	5.75	—	11.6	7.68	3.17	3.1	2.74	2.44	2.91
Earnings yield	3.46%	3.88%	0.64%	—	—	—	—	—	0%	—	-4.81%
FCF yield	11.2%	7.48%	6.44%	—	-8.22%	2.42%	16%	12.1%	16.9%	18.9%	12.3%
PEG	—	—	—	—	—	—	—	—	—	—	-0.1

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	34.5%	32.9%	31.7%	31.8%	-11.5%	17%	27.5%	24.9%	25.2%	24.2%	30.1%
Operating margin	18.6%	15.7%	17.4%	14.6%	-73.4%	-19.1%	7.05%	3.96%	5.75%	5.1%	14.3%
Net margin	9.06%	13%	1.62%	7.18%	-88.6%	-25.4%	-6.11%	-5.23%	0%	-4.22%	-3.11%
ROE	4.6%	6.67%	0.36%	3.19%	-12%	-5.89%	-2.76%	-2.61%	0%	-2.43%	-1.63%
ROA	2.63%	3.87%	0.19%	1.78%	-6.46%	-2.98%	-1.39%	-1.28%	0%	-1.16%	1.28%
ROIC	5.71%	5%	1.98%	3.55%	-5.48%	-2.38%	1.71%	1.06%	1.62%	1.56%	2.39%
Return on tangible assets	2.63%	3.87%	0.19%	1.78%	-6.46%	-2.98%	-1.39%	-1.28%	0%	-1.16%	-0.81%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	0.58	0.52	0.53	0.44	0.7	0.38	0.11	0.3	0.72	0.7	0.71
Quick ratio	0.58	0.52	0.53	0.44	0.7	0.38	0.11	0.3	0.72	0.7	0.44
Debt / equity	0.67	0.62	0.73	0.75	0.85	0.87	0.88	0.93	0.92	0.96	0.98
Debt / assets	0.38	0.36	0.39	0.42	0.46	0.44	0.44	0.45	0.45	0.46	0.46
Net debt / EBITDA	5.53	4.06	10.6	5.86	-24.9	36.1	8.29	8.38	7.72	7.46	6.57
Interest coverage	2.81	3.88	1.29	2.19	-3.09	-1.14	-0.01	0.32	0.75	0.45	0.66
Effective tax rate	0%	0.18%	11.5%	4.28%	0%	0%	0%	0%	0%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	11.4	11.1	11.2	12.4	3.39	5.6	10.7	11.7	12.1	12.6	13.1
EPS (basic)	0.65	1.2	-0.06	0.63	-3.25	-1.8	-0.95	-0.93	-0.39	-0.9	-0.9
EPS (diluted)	0.64	1.19	-0.06	0.63	-3.25	-1.8	-0.95	-0.93	-0.39	-0.9	-0.68
Book value per share	22.4	21.6	50.7	27.8	25	24.2	23.6	23.4	23.3	21.9	21.5
FCF per share	3.34	2.78	1.82	3.03	-1.54	0.54	2.14	1.94	2.3	2.13	2.2
Cash per share	0.46	0.37	1.12	0.23	0.95	0.45	0.31	1.51	1.73	1.57	2.37
Capex per share	0	0	0	0.01	0	—	—	—	—	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	0.01%	0.01%	0.02%	0.05%	0%	—	—	—	—	—	—
Capex / operating cash flow	0.04%	0.02%	0.1%	0.19%	0%	—	—	—	—	—	—
Payout ratio	171.8%	123.1%	910.1%	187.9%	-22%	-24%	-62%	-72.1%	325.3K%	-83.4%	126.4%
Dividend yield	5.94%	4.77%	5.79%	—	3.52%	1.53%	3.01%	2.75%	3.21%	3.92%	0.21%

Yield

0.21%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.01

ex-dividend Jun 30, 2026

Payout ratio

126%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jun 30, 2026	$0.01
Mar 31, 2026	$0.01
Dec 31, 2025	$0.01

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$395.8M	$334.1M	$314.1M	$397.1M	$404.5M	$337.6M	$320.3M	$407.5M	$398.7M	$349M	$345.7M	$407.1M
YoY change	-5.01%	+4.53%	+2.73%	+3.32%	+2.21%	+1.05%	+1.97%	+2.63%	-1.44%	+3.38%	+7.93%	-0.1%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	33.4M	25.4M	83.4M	30.1M	124.3M	58.5M	41M	183.7M	206.7M	184.2M
Receivables	27.7M	29.2M	59.9M	49.6M	10.2M	37M	45.3M	43.9M	39.1M	34.2M
Inventory	—	—	—	—	—	—	—	—	—	—
Total current assets	107M	105.4M	244.4M	166M	194.3M	129.3M	97.5M	237.6M	256.7M	230.4M
Property, plant & equipment	29.6M	29M	199.7M	0	—	—	—	—	—	—
Goodwill & intangibles	—	—	—	—	—	—	—	—	—	—
Total assets	2.8B	2.6B	7B	6.5B	6.1B	6.3B	6.1B	5.8B	5.7B	5.3B
Accounts payable	149.3M	141.3M	360.3M	260.2M	226.4M	250.6M	250.5M	238.6M	222.2M	199.6M
Short-term debt	82M	45M	—	256.3M	255.1M	—	507.6M	460M	17.2M	—
Total current liabilities	184.8M	202.1M	461.5M	381.1M	276.5M	336M	848.9M	794.2M	355.2M	328.3M
Long-term debt	996.3M	885.2M	2.7B	2.5B	2.5B	2.8B	2.2B	2.2B	2.6B	2.5B
Total liabilities	1.2B	1.1B	3.2B	2.9B	2.8B	3.1B	3B	3B	2.9B	2.8B
Shareholders' equity	1.6B	1.5B	3.8B	3.6B	3.3B	3.2B	3.1B	2.9B	2.8B	2.6B
Total debt	1.1B	930.2M	2.7B	2.7B	2.8B	2.8B	2.7B	2.6B	2.6B	2.5B
Net debt	1B	904.8M	2.7B	2.7B	2.7B	2.7B	2.7B	2.5B	2.4B	2.3B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	182.7M	183.7M	56.7M	101.7M	134M	206.7M	208.1M	256.1M	223.2M	184.2M	196.2M	261M
Receivables	56.8M	43.9M	53.9M	63.6M	61M	39.1M	43.2M	49.7M	45.7M	34.2M	39.7M	44.3M
Inventory	—	—	—	—	—	—	—	—	—	—	—	—
Total current assets	248.5M	237.6M	118.9M	174.7M	205.3M	256.7M	261.4M	316.8M	277.8M	230.4M	244.3M	314.7M
Property, plant & equipment	—	—	—	—	—	—	—	—	—	—	—	—
Goodwill & intangibles	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	6B	5.8B	5.7B	5.7B	5.7B	5.7B	5.7B	5.7B	5.6B	5.3B	5.3B	5.3B
Accounts payable	272.7M	238.6M	247M	238.4M	243.9M	222.2M	219M	232.1M	228.1M	199.6M	215.7M	221.7M
Short-term debt	—	460M	43.3M	—	—	17.2M	17.2M	17.2M	17.2M	—	360M	360M
Total current liabilities	371.8M	794.2M	400.5M	342M	352.3M	355.2M	373.2M	355.7M	391.7M	328.3M	720.3M	711.6M
Long-term debt	2.7B	2.2B	2.5B	2.5B	2.5B	2.6B	2.6B	2.6B	2.6B	2.5B	2.1B	2.1B
Total liabilities	3.1B	3B	2.9B	2.9B	2.9B	2.9B	2.9B	2.9B	2.9B	2.8B	2.8B	2.8B
Shareholders' equity	2.9B	2.9B	2.8B	2.8B	2.8B	2.8B	2.7B	2.7B	2.6B	2.6B	2.5B	2.5B
Total debt	2.7B	2.6B	2.5B	2.5B	2.5B	2.6B	2.6B	2.6B	2.6B	2.5B	2.4B	2.4B
Net debt	2.5B	2.5B	2.5B	2.4B	2.4B	2.4B	2.4B	2.3B	2.3B	2.3B	2.2B	2.2B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	74M	100.3M	13.4M	115.7M	-392.6M	-186.4M	-85M	-74.3M	16K	-62.2M
Depreciation & amortization	102.4M	102.3M	108.5M	234.9M	224.6M	224.3M	239.6M	240.6M	229.5M	227.7M
Stock-based compensation	8.5M	5.6M	6.2M	8.2M	22.8M	11.4M	11.3M	12.5M	13.6M	13.7M
Change in working capital	3.6M	769K	7.7M	12.6M	19.9M	-1.8M	-4.1M	8.7M	23.8M	21.9M
Operating cash flow	195.4M	216.3M	160.1M	397.6M	-101.6M	69.3M	180.5M	201.8M	232.4M	249.7M
Capital expenditure	-74K	-40K	-164K	-752K	0	—	—	—	—	—
Investing cash flow	52.5M	7.6M	-1.7B	-1.5M	0	-128K	5.6M	27.7M	35.9M	5.1M
Dividends paid	-127.1M	-123.4M	-121.8M	-217.4M	-86.5M	-44.7M	-52.7M	-53.6M	-52M	-51.9M
Share repurchases	-227.5M	-96M	-2.5M	-4M	-1.3M	-250.7M	-86.7M	-108.5M	-16.9M	-78.7M
Financing cash flow	-532.9M	-334.2M	1.7B	-746.1M	69.4M	-12.3M	-209.3M	-236.8M	-158.2M	-254.2M
Net change in cash	-285M	-110.3M	160.7M	-350M	-32.2M	56.9M	-23.2M	-7.3M	110.1M	612K
Free cash flow	239.9M	193.6M	135.5M	395.2M	-201.8M	70.8M	278.7M	236.2M	275M	249.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	—	—	—	—	—	—	—	—	-32.4M	-17M	-18.4M	24.9M
Depreciation & amortization	—	—	—	—	—	—	—	—	57.6M	54.9M	52M	52.1M
Stock-based compensation	—	—	—	—	—	—	—	—	3.5M	3.5M	2.3M	2.6M
Change in working capital	—	—	—	—	—	—	—	—	575K	23.1M	4.4M	-10.9M
Operating cash flow	5M	4.6M	5M	3.8M	3.7M	-18.5M	6.6M	3.9M	77.6M	31.3M	84.1M	86.3M
Capital expenditure	—	—	—	—	—	—	—	—	—	—	—	—
Investing cash flow	—	—	—	—	—	—	—	—	2.8M	282K	3M	-44K
Dividends paid	—	—	—	—	—	—	—	—	-13M	-12.9M	-12.7M	-12.7M
Share repurchases	—	—	—	—	—	—	—	—	-51.1M	-12M	-5.9M	-10.4M
Financing cash flow	—	—	—	—	—	—	—	—	-94.1M	-116.2M	-66.7M	-24.1M
Net change in cash	5M	4.6M	5M	3.8M	3.7M	-18.5M	6.6M	3.9M	-13.8M	-84.7M	20.3M	62.2M
Free cash flow	—	—	—	—	—	—	—	—	77.6M	31.3M	84.1M	86.3M

Pebblebrook Hotel Trust Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement